申请人:Astellas Pharma Inc.
公开号:EP2096109A1
公开(公告)日:2009-09-02
To provide a compound which is usable as a drug, in particular, an insulin secretagogue or a preventive or remedy for a disease in which GPR40 participates such as diabetes or the like. [MEANS FOR SOLVING PROBLEMS] If is found out that a novel carboxylic acid derivative, which is characterized in that a carboxylic acid is bonded via two atoms to a 6-membered monocyclic aromatic ring and this aromatic ring is further bonded via a linker to a nitrogen-containing bicyclic ring, or its salt has an excellent GPR40 agonist activity, Because of showing excellent effects of promoting insulin secretion and lowering blood glucose level, this carboxylic acid derivative is useful as an insulin secretagogue or a preventive or remedy for diabetes.
提供一种可用作药物的化合物,特别是胰岛素分泌素或参与 GPR40 参与的疾病的预防或治疗,如糖尿病等。【解决问题的方法】发现一种新型羧酸衍生物,其特征在于羧酸通过两个原子与一个6-成员单环芳香环结合,而这个芳香环通过连接剂与含氮双环环结合,或其盐具有出色的 GPR40 激动剂活性,由于显示出促进胰岛素分泌和降低血糖水平的出色效果,这种羧酸衍生物可用作胰岛素分泌素或糖尿病的预防或治疗。